BioAuthorize Launches Its New yadaBlackBook(TM) Application for the iPhone and iPod Touch, Enabling Users to Protect Their Contacts Using Their Voice
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--On July 12, 2009, BioAuthorize Holdings, Inc. (OTCBB: BAZH) of Scottsdale, through its wholly owned subsidiary, BioAuthorize, Inc., received final approval from Apple, Inc. to launch its next application for the iPhone and iPod Touch, yadaBlackBook^TM, which allows users to protect and maintain as secret, the content of their contacts by using their voice to authenticate their identity. The application is offered through the Apple App Store at $3.99 per download.

Go to www.yadablackbook.com for additional detailed information and a video presentation of the application.

"This application utilizes advanced voice biometrics to maintain the secrecy of your contact list with a solution that is needed by everyone using an iPhone or iPod Touch," said BioAuthorize president and CEO Yada Schneider.

About BioAuthorize Holdings, Inc.

BioAuthorize Holdings, Inc., together with its subsidiary BioAuthorize, Inc. (www.bioauthorize.com), is a hi-tech biometric technology company which has developed a technology solution for e-commerce transactions related to the delivery of voice-enabled payment solution process to merchants and their customers for Internet purchases and the developer of the yada^TM line of products for both the iPhone and the Blackberry handheld personal electronic devices.

Statements about BioAuthorize Holdings' ongoing business strategies or prospects, the functionality of and acceptance in the marketplace of our voice-authentication technology and iPhone and Blackberry applications, and possible future actions and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. BioAuthorize Holdings intends that such forward-looking statements be subject to the safe harbors created thereby. These future events may not occur as and when expected, if at all, and, together with BioAuthorize Holdings' business, are subject to various risks and uncertainties. BioAuthorize Holdings' actual results could differ materially from expected results as a result of a number of factors, including the uncertainties inherent in the offering and acceptance in the marketplace of new technology products, the evaluation of potential opportunities, the level of corporate expenditures and monies available for further studies, capital market conditions, and others set forth in BioAuthorize Holdings' periodic reports on Form 10-K for the year ended December 31, 2008 and on Form 10-Q for the quarter ended March 31, 2009 as filed with the Securities and Exchange Commission. There are no guarantees that any of BioAuthorize Holdings' proposed products will prove to be commercially successful. BioAuthorize Holdings undertakes no duty to update forward-looking statements.

Contacts
BioAuthorize Holdings Inc. & BioAuthorize Inc.
Kim Garvey, 602-862-0291
ComsMgt@aol.com